
Agnieszka Boesen
Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1050 |
| Issued Applications | 614 |
| Pending Applications | 117 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9476741
[patent_doc_number] => 20140134204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'METHODS OF IMPROVING VACCINE IMMUNOGENICITY'
[patent_app_type] => utility
[patent_app_number] => 14/110101
[patent_app_country] => US
[patent_app_date] => 2012-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21580
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110101
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110101 | Methods of improving vaccine immunogenicity | Apr 3, 2012 | Issued |
Array
(
[id] => 9476743
[patent_doc_number] => 20140134206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'INFLAMMATION AND IMMUNITY TREATMENTS'
[patent_app_type] => utility
[patent_app_number] => 14/008995
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9929
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008995
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008995 | Inflammation and immunity treatments | Mar 29, 2012 | Issued |
Array
(
[id] => 9482774
[patent_doc_number] => 08728723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism'
[patent_app_type] => utility
[patent_app_number] => 13/435325
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 17444
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435325
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/435325 | Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism | Mar 29, 2012 | Issued |
Array
(
[id] => 8885049
[patent_doc_number] => 20130158233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-20
[patent_title] => 'METHOD FOR SIMULTANEOUSLY DETECTING AN ANTIGEN OF, AND AN ANTIBODY, AGAINST, AN INFECTIOUS MICROORGANISM'
[patent_app_type] => utility
[patent_app_number] => 13/435381
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17378
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13435381
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/435381 | Method for simultaneously detecting an antigen of, and an antibody, against, an infectious microorganism | Mar 29, 2012 | Issued |
Array
(
[id] => 8453163
[patent_doc_number] => 20120264109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-18
[patent_title] => 'LYMPHOCYTE ANALYSIS FOR MONITORING THE PROGRESSION OF IMMUNODEFICIENCY VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/432542
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4023
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13432542
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/432542 | LYMPHOCYTE ANALYSIS FOR MONITORING THE PROGRESSION OF IMMUNODEFICIENCY VIRUS | Mar 27, 2012 | Abandoned |
Array
(
[id] => 9197614
[patent_doc_number] => 20130336929
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'METHODS AND CELLS FOR IDENTIFYING RIG-I PATHWAY REGULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/001472
[patent_app_country] => US
[patent_app_date] => 2012-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17815
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14001472
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/001472 | Methods and cells for identifying RIG-I pathway regulators | Feb 22, 2012 | Issued |
Array
(
[id] => 11794129
[patent_doc_number] => 09403879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-02
[patent_title] => 'Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same'
[patent_app_type] => utility
[patent_app_number] => 13/984771
[patent_app_country] => US
[patent_app_date] => 2012-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 20
[patent_no_of_words] => 14475
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984771
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/984771 | Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same | Feb 12, 2012 | Issued |
Array
(
[id] => 10850527
[patent_doc_number] => 08877205
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-04
[patent_title] => 'Yeast-based therapeutic for chronic hepatitis B infection'
[patent_app_type] => utility
[patent_app_number] => 13/984888
[patent_app_country] => US
[patent_app_date] => 2012-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 42
[patent_no_of_words] => 96296
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984888
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/984888 | Yeast-based therapeutic for chronic hepatitis B infection | Feb 8, 2012 | Issued |
Array
(
[id] => 8963030
[patent_doc_number] => 20130202632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'MINIMAL MOTIFS OF LINEAR B-CELL EPITOPES IN L1 PROTEIN FROM HUMAN PAPILLOMAVIRUS TYPE 58 AND THEIR APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/364952
[patent_app_country] => US
[patent_app_date] => 2012-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8685
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13364952
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/364952 | Minimal motifs of linear B-cell epitopes in L1 protein from human papillomavirus type 58 and their applications | Feb 1, 2012 | Issued |
Array
(
[id] => 14548849
[patent_doc_number] => 10342862
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-09
[patent_title] => RSV immunization regimen
[patent_app_type] => utility
[patent_app_number] => 13/982206
[patent_app_country] => US
[patent_app_date] => 2012-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 33897
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982206
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/982206 | RSV immunization regimen | Jan 25, 2012 | Issued |
Array
(
[id] => 9307365
[patent_doc_number] => 20140046039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'ANTIBODIES DIRECTED AGAINST INFLUENZA'
[patent_app_type] => utility
[patent_app_number] => 13/978607
[patent_app_country] => US
[patent_app_date] => 2012-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 53
[patent_figures_cnt] => 53
[patent_no_of_words] => 20156
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13978607
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/978607 | Antibodies directed against influenza | Jan 9, 2012 | Issued |
Array
(
[id] => 8289755
[patent_doc_number] => 20120178079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'Human Bocavirus and Methods of Diagnosis and Treatment'
[patent_app_type] => utility
[patent_app_number] => 13/339743
[patent_app_country] => US
[patent_app_date] => 2011-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9623
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339743
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/339743 | Human bocavirus and methods of diagnosis and treatment | Dec 28, 2011 | Issued |
Array
(
[id] => 8891131
[patent_doc_number] => 20130164315
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'Vaccines - Screening Method'
[patent_app_type] => utility
[patent_app_number] => 13/336648
[patent_app_country] => US
[patent_app_date] => 2011-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18510
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13336648
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/336648 | Vaccines - Screening Method | Dec 22, 2011 | Abandoned |
Array
(
[id] => 9244830
[patent_doc_number] => 08609109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-12-17
[patent_title] => 'HIV vaccine formulations'
[patent_app_type] => utility
[patent_app_number] => 13/334739
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 22682
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13334739
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/334739 | HIV vaccine formulations | Dec 21, 2011 | Issued |
Array
(
[id] => 8183976
[patent_doc_number] => 20120114590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'IL28 AND IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/331000
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55409
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20120114590.pdf
[firstpage_image] =>[orig_patent_app_number] => 13331000
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/331000 | IL28 AND IL29 TRUNCATED CYSTEINE MUTANTS AND ANTIVIRAL METHODS OF USING SAME | Dec 19, 2011 | Abandoned |
Array
(
[id] => 8138607
[patent_doc_number] => 20120093849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'Agents for Treatment of HCV and Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 13/326793
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16815
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20120093849.pdf
[firstpage_image] =>[orig_patent_app_number] => 13326793
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/326793 | Agents for treatment of HCV and methods of use | Dec 14, 2011 | Issued |
Array
(
[id] => 9318741
[patent_doc_number] => 20140051079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT AGAINST HEPATITIS C'
[patent_app_type] => utility
[patent_app_number] => 13/993991
[patent_app_country] => US
[patent_app_date] => 2011-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4107
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993991
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/993991 | METHOD FOR PREDICTING THE RESPONSE TO A TREATMENT AGAINST HEPATITIS C | Dec 13, 2011 | Abandoned |
Array
(
[id] => 10620608
[patent_doc_number] => 09339535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-17
[patent_title] => 'Vaccines and immunopotentiating compositions and methods for making and using them'
[patent_app_type] => utility
[patent_app_number] => 13/324887
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 27867
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13324887
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/324887 | Vaccines and immunopotentiating compositions and methods for making and using them | Dec 12, 2011 | Issued |
Array
(
[id] => 9318416
[patent_doc_number] => 20140050754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'IMMUNOGENIC CHIKUNGUNYA VIRUS PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/992126
[patent_app_country] => US
[patent_app_date] => 2011-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 26008
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13992126
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/992126 | IMMUNOGENIC CHIKUNGUNYA VIRUS PEPTIDES | Dec 11, 2011 | Abandoned |
Array
(
[id] => 8509186
[patent_doc_number] => 20120308594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'HCV CLADE AND PROTOTYPE SEQUENCES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/315569
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25021
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13315569
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/315569 | HCV CLADE AND PROTOTYPE SEQUENCES THEREOF | Dec 8, 2011 | Abandoned |